STI Testing Explained: What Each Quarterly Test Looks For

If you're on PrEP or DoxyPEP, you hand over blood, urine, and a couple of swabs every few months, and a week later a portal says "not detected" a dozen times. Few people are ever told what each line was looking for, what a negative does and doesn't rule out, or why some infections aren't on the panel at all. Here's the test-by-test breakdown.

Why the schedule is every three months

The quarterly rhythm comes from PrEP. CDC's PrEP guidance calls for a repeat HIV antigen/antibody test and an HIV-1 RNA test at least every 3 months on oral PrEP, with prescriptions of no more than 90 days so the refill and the test stay tied together. STI screening rides along, but the official intervals depend on who you are:

CDC's STI treatment guidelines say much the same: at least annual screening for sexually active gay and bisexual men, tightening to every 3 to 6 months for those on PrEP or with ongoing risk. So "quarterly" is the frequent end of the recommended range, not a universal rule. Symptoms get tested right away, whatever the calendar says.

The HIV tests: antigen/antibody plus RNA

These are two tests looking for different things. The antigen/antibody test looks for the antibodies your immune system makes against HIV and for p24 antigen, a piece of the virus that shows up before antibodies do. The HIV-1 RNA test (a nucleic acid test, or NAT) looks for the virus's genetic material directly, which makes it the earliest test to turn positive.

Why both? Because PrEP itself complicates testing. CDC's PrEP guideline notes that antiretrovirals can suppress early viral replication and shift the timing of antibody development, so in the uncommon case that someone acquires HIV while on PrEP, an antibody-based test alone can lag behind. The RNA test is the backstop. It's also why CDC says oral-swab HIV self-tests are usually not recommended for people on PrEP. On injectable PrEP, HIV tests are tied to injection visits rather than a quarterly clock (the PrEP visit walkthrough has the full lab list).

Syphilis: one blood draw, two kinds of test

Syphilis is checked from blood, and CDC's guidelines say a presumptive diagnosis takes two types of test: a treponemal test, which looks for antibodies specific to the syphilis bacterium, and a nontreponemal test (usually an RPR), which measures a less specific antibody response and reports it as a titer such as 1:8 or 1:32. Either alone can mislead: nontreponemal tests can be falsely positive for unrelated reasons, and a single test can miss infection in the primary stage.

The detail that confuses people most: if you've ever had syphilis, the treponemal test usually stays reactive for life, even after successful treatment. That is not a new infection. What your clinician watches is the RPR titer, which tracks disease activity — CDC treats a fourfold change (for example, 1:4 to 1:16) as the threshold that means something. If you've been treated before, say so. And a new sore deserves an exam even when your last blood test was clean.

Gonorrhea and chlamydia: same test, up to three sites

These are found with a nucleic acid amplification test (NAAT), which detects the bacteria's genetic material in a sample from wherever the infection might be living. That's the catch: an infection in your throat or rectum won't show up in a urine cup. CDC's PrEP guideline calls for three-site testing in gay and bisexual men because infection can occur at any of those sites, and its STI guidelines match each sample to the sex you actually have: urine for insertive sex, a rectal swab for receptive anal sex, a throat swab for receptive oral sex. For people with a vagina, a vaginal swab or urine covers the genital site.

You'll usually collect the throat and rectal swabs yourself, and that's fine: CDC's PrEP guideline says self-collected samples perform as well as clinician-collected ones. CDC recommends throat screening for gonorrhea but not for chlamydia specifically, so a throat result may list one infection or both depending on the lab. If a service only ever sends a urine cup, ask for the swabs.

The tests that aren't every quarter

Hepatitis B is a three-part blood panel (surface antigen, core antibody, surface antibody) that sorts out whether you're currently infected, immune, or due for a vaccine. It's done before starting oral PrEP, and CDC's STI guidelines recommend it for all gay and bisexual men. Hepatitis C starts with an antibody test; a reactive result is followed by an RNA test to tell a past, cleared infection from a current one. CDC recommends every adult be tested at least once, with repeat testing for ongoing exposure such as shared injection equipment. How often PrEP clinics repeat it otherwise varies, so ask what yours does. And the creatinine line on your results isn't an STI test at all — it's the kidney safety check for oral PrEP, done every 6 to 12 months.

What a standard panel doesn't look for

"I got tested for everything" is almost never literally true, and mostly that's on purpose.

• Herpes. CDC does not recommend herpes blood testing for people without symptoms in most situations, because the chance of a false positive is much higher than with chlamydia or gonorrhea tests.
• HPV. CDC says HPV tests aren't recommended to screen men, and there's no approved test for HPV in the mouth or throat. HPV testing is a cervical cancer screening tool.
• Mycoplasma genitalium. CDC recommends against screening people without symptoms and against throat or rectal testing. More on M. gen here.

None of this means those infections don't matter. Symptoms change the picture — tell your clinician and the testing changes with it.

Window periods: what "negative" actually covers

No test can detect an infection the day after you get it. The gap between exposure and the point a test can pick it up is the window period, and a negative only speaks to infections older than that. CDC publishes these ranges for HIV tests:

For syphilis and for the gonorrhea and chlamydia swabs, CDC's guidelines don't give an equivalent single number, and we're not going to invent one. A test taken a few days after a specific encounter may be too early, so if you're testing because of one particular exposure, tell the clinician the date; it affects which test they choose and whether they'll want a repeat. And if that exposure could have been to HIV within the last 72 hours, that's a PEP situation, not a testing one.

If something comes back positive

For syphilis, gonorrhea, and chlamydia, a positive is a treatable result, not a verdict. You'll get antibiotics chosen for that infection, recent partners should be told so they can be tested and treated, and your clinician will tell you how long to hold off on sex afterward. A positive while taking DoxyPEP doesn't mean you did it wrong: DoxyPEP lowers the odds of these infections, it doesn't erase them, which is why CDC keeps the screening schedule in place for people who use it.

A reactive HIV test while on PrEP is uncommon and needs confirmatory testing before anyone draws conclusions. Don't stop or restart pills on your own; contact your prescriber the same day.

When to talk to a clinician

Don't wait for your next scheduled panel if you have discharge, burning, a sore or rash, rectal pain or bleeding, or a partner who tells you they tested positive. The same goes for a fever-and-body-aches illness in the weeks after a possible HIV exposure, on PrEP or not. For routine screening, our reviewing clinical team runs PrEP and DoxyPEP visits, including the lab orders, by telehealth; the $25/month membership covers the visits and lab coordination, and you can book a visit directly.